Literature DB >> 22215890

Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.

Christopher B Granger1, Luciana V Armaganijan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22215890     DOI： 10.1161/CIRCULATIONAHA.111.031146

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  Interrupting anticoagulation in patients with nonvalvular atrial fibrillation.

Authors:  Scott W Yates
Journal:  P T       Date:  2014-12

Review 2.  Direct acting oral anticoagulant: Bench to bedside.

Authors:  D S Chadha; P Bharadwaj
Journal:  Med J Armed Forces India       Date:  2017-01-03

3.  TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillation.

Authors:  Alejandro Isidoro Pérez Cabeza; Rafael Bravo Marques; Pedro Antonio Chinchurreta Capote; Francisco Ruiz Mateas; Christina L Fanola; Gabriel Rosas Cervantes; Jose Antonio González Correa; Almudena Valle Alberca; Fidel Mesa Prado; Sergio López Tejero; Christian Thomas Ruff
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

Review 4.  Anticoagulants in atrial fibrillation patients with chronic kidney disease.

Authors:  Robert G Hart; John W Eikelboom; Alistair J Ingram; Charles A Herzog
Journal:  Nat Rev Nephrol       Date:  2012-07-24       Impact factor: 28.314

Review 5.  Enhanced elimination of dabigatran through extracorporeal methods.

Authors:  Nadia I Awad; Luigi Brunetti; David N Juurlink
Journal:  J Med Toxicol       Date:  2015-03

6.  The impact of surgical left atrial appendage amputation/ligation on stroke prevention in patients undergoing off-pump coronary artery bypass grafting.

Authors:  Daisuke Endo; Tomoko S Kato; Tai Iwamura; Atsumi Oishi; Yasutaka Yokoyama; Kenji Kuwaki; Hirotaka Inaba; Atsushi Amano
Journal:  Heart Vessels       Date:  2016-11-09       Impact factor: 2.037

Review 7.  Rivaroxaban: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Authors:  Natalie J Carter; Greg L Plosker
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

Review 8.  Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.

Authors:  Daniel T Lackland; Edward J Roccella; Anne F Deutsch; Myriam Fornage; Mary G George; George Howard; Brett M Kissela; Steven J Kittner; Judith H Lichtman; Lynda D Lisabeth; Lee H Schwamm; Eric E Smith; Amytis Towfighi
Journal:  Stroke       Date:  2013-12-05       Impact factor: 7.914

9.  The new anticoagulant drugs: are they really superior to warfarin?

Authors:  Costas Thomopoulos; Costas Tsioufis
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-03       Impact factor: 3.738

Review 10.  Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI.

Authors:  Andreas Schäfer; Ulrike Flierl; Johann Bauersachs
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.